Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Angiogenesis in Lymphoproliferative Disorders

Acta Haematol (2001) 106 (4): 184–189.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphoma
  • Shentong Fang
  • Heikki Repo
  • Heikki Joensuu
  • Arto Orpana
  • Petri Salven
European Journal of Cancer (2011) 47 (11): 1708.
Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas
  • E Dejean
  • M H Renalier
  • M Foisseau
  • X Agirre
  • N Joseph
  • G R de Paiva
  • T Al Saati
  • J Soulier
  • C Desjobert
  • L Lamant
  • F Prósper
  • D W Felsher
  • J Cavaillé
  • H Prats
  • G Delsol
  • S Giuriato
  • F Meggetto
Leukemia (2011) 25 (12): 1882.
Histological expression of angiogenic factors: VEGF, PDGFRα, and HIF-1α in Hodgkin lymphoma
  • Freda H. Passam
  • Michael G. Alexandrakis
  • Maria Kafousi
  • Marianthi Fotinou
  • Katerina Darivianaki
  • George Tsirakis
  • Paraskevi A. Roussou
  • Efstathios N. Stathopoulos
  • Nikolaos M. Siafakas
Pathology - Research and Practice (2009) 205 (1): 11.
The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas
  • Semra Paydas
  • Gulsah Seydaoglu
  • Melek Ergin
  • Seyda Erdogan
  • Sinan Yavuz
Leukemia & Lymphoma (2009) 50 (3): 366.
Simultaneous Quantification of Erlotinib, Gefitinib, and Imatinib in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry
  • A Chahbouni
  • J C G den Burger
  • R M Vos
  • A Sinjewel
  • A J Wilhelm
Therapeutic Drug Monitoring (2009) 31 (6): 683.
Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia
  • A. G. Zhelyazkova
  • A. B. Tonchev
  • P. Kolova
  • L. Ivanova
  • L. Gercheva
Scandinavian Journal of Clinical and Laboratory Investigation (2008) 68 (6): 492.
Angiogenesis‐related growth factors and cytokines in the serum of patients with B non‐Hodgkin lymphoma; relation to clinical features and response to treatment
  • F. H. PASSAM
  • A. SFIRIDAKI
  • C. PAPPA
  • D. KYRIAKOU
  • E. PETRELI
  • P. A. ROUSSOU
  • M. G. ALEXANDRAKIS
International Journal of Laboratory Hematology (2008) 30 (1): 17.
Angiogenic Molecules in Hodgkin's Disease: Results from Sequential Serum Analysis
  • F.H. Passam
  • M.G. Alexandrakis
  • J. Moschandrea
  • A. Sfiridaki
  • P.A. Roussou
  • N.M. Siafakas
International Journal of Immunopathology and Pharmacology (2006) 19 (1): 205873920601900.
Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity
  • Siqing Shan
  • Clay Flowers
  • Cathy D. Peltz
  • Heather Sweet
  • Norbert Maurer
  • Eun-Joo Gina Kwon
  • Ave Krol
  • Fan Yuan
  • Mark W. Dewhirst
Cancer Chemotherapy and Pharmacology (2006) 58 (2): 245.
Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogs
  • Fabio Gentilini
  • Claudia Calzolari
  • Maria Elena Turba
  • Chiara Agnoli
  • Davide Fava
  • Monica Forni
  • Paolo Famigli Bergamini
Leukemia Research (2005) 29 (11): 1263.
Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin’s lymphoma
  • Lars Møller Pedersen
  • Tobias Wirenfeldt Klausen
  • Ulla Høy Davidsen
  • Hans Erik Johnsen
Annals of Hematology (2005) 84 (8): 510.
Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma
  • Maurizio Zangari
  • Elias Anaissie
  • Alison Stopeck
  • Alyssa Morimoto
  • Nguyen Tan
  • Jeffrey Lancet
  • Maureen Cooper
  • Alison Hannah
  • Guillermo Garcia-Manero
  • Stephan Faderl
  • Hagop Kantarjian
  • Julie Cherrington
  • Maher Albitar
  • Francis J. Giles
Clinical Cancer Research (2004) 10 (1): 88.
The importance of angiogenesis in ovarian cancer
  • Lorenzo Alonso Carrión
  • Francisco Jesús González Sánchez
  • Emilio Alba Conejo
  • Esperanza Torres Sánchez
Clinical and Translational Oncology (2004) 6 (8): 462.
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin’s lymphoma or Hodgkin’s lymphoma
  • Francis J Giles
  • Julie M Vose
  • Kim-Anh Do
  • Marcella M Johnson
  • Taghi Manshouri
  • Gregory Bociek
  • Philip J Bierman
  • Susan M O’Brien
  • Hagop M Kantarjian
  • James O Armitage
  • Maher Albitar
Leukemia Research (2004) 28 (6): 595.
Thalidomide and immunomodulatory drugs as cancer therapy
  • Noopur Raje
  • Kenneth C. Anderson
Current Opinion in Oncology (2002) 14 (6): 635.
  • Online ISSN 1421-9662
  • Print ISSN 0001-5792
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal